Oerlikon sales increase in first half of 2019

Oerlikon sales increase in first half of 2019

The Group succeeded in increasing sales by 5.3 per cent to CHF 700 million, underlining Oerlikon’s structural growth and resilient business model built on technology leadership in long-term attractive markets.

The Group succeeded in increasing sales by 5.3 per cent to CHF 700 million, underlining Oerlikon’s structural growth and resilient business model built on technology leadership in long-term attractive markets.

Dr Roland Fischer, CEO, Oerlikon Group, said, “In the increasingly challenging market environment, we delivered a good performance for the second quarter and for the first half of 2019, driven by strong results of our man-made fibres business. We increased Group sales and sustained operating profitability. Group orders came in slightly lower in the second quarter due to weak markets. The results underscore the resilience of our business while facing tough markets and confirm that we have a sound strategy and business model.”

“Economic growth around the world is stalling, resulting in lower investments in equipment and industrial production. These developments have impacted most of our end markets, from automotive to tooling and general industries, encompassing sectors such as semiconductors and electronics. While we still benefit from our structural growth initiatives, we have started to see weakening in our surface solutions business as reflected in the segment’s top line, margin and margin quality. Amid mounting geopolitical and market uncertainties, and given that the anticipated market recovery for our surface solutions business in the second half of the year is no longer visible, we are adjusting our guidance for 2019,” added Dr Fischer. “Based on our reassessment, we expect to deliver around the same level of performance as for the full-year 2018.”

Oerlikon second quarter review

In the second quarter of 2019, the global economy further slowed down, exacerbated by drawn-out trade disputes. Significantly weaker-than-expected industrial production translated to lower volumes, and consequently reining in of investments for equipment and declining demand for services. These developments were registered across multiple markets, including automotive, tooling and general industries, and partly in aerospace.

Facing adverse market trends, the Group’s order intake slightly decreased year-on-year by 0.7 per cent to CHF 672 million. However, the Group succeeded in increasing sales by 5.3 per cent to CHF 700 million, underlining Oerlikon’s structural growth and resilient business model built on technology leadership in long-term attractive markets. At constant exchange rates, sales stood at CHF 720 million. EBITDA for the second quarter increased to CHF 121 million, corresponding to a margin of 17.3 per cent. EBIT for Q2 2019 was at CHF 70 million, or 10.1 per cent of sales. The second-quarter performance resulted in a rolling 12-month Oerlikon Group return on capital employed (ROCE) of 9.5 per cent.

Oerlikon half-year overview

In the first half of 2019, the Group’s order intake declined year-on-year by 5.7 per cent to CHF 1 352 million, primarily due to the record level of orders in the man-made fibres business in the first half of 2018. Sales came in 4.3 per cent higher than the prior year, reaching CHF 1 324 million. With the increase in sales, the EBITDA for the half year amounted to CHF 214 million, corresponding to a margin of 16.2 per cent. EBIT stood at CHF 115 million, or 8.7 per cent of sales. The results from continuing operations for the half year came in at CHF 80 million – a 12 per cent decrease year-over-year, primarily due to an increase in the cost of sales. The net result for the first half of the year was CHF -99 million, including the one-time non-cash reclassification of translation differences in the amount of CHF -284 million and other items from other comprehensive income from the divestment of the Drive Systems Segment. In the first six months of 2019, Oerlikon’s service business contributed to 38.3 per cent of total Group sales (2018: 39.0 per cent).

As of June 30, 2019, Oerlikon had equity (attributable to shareholders of the parent) of CHF 1,798 million, representing an equity ratio of 48 per cent (year end 2018: 44 per cent). Net cash on June 30, 2019 amounted to CHF 380 million (year end 2018: CHF 398 million) after dividend payouts of CHF 1 per share and the repayment of a CHF 300 million Swiss bond. Cash flow from operating activities for the first half of 2019 decreased to CHF -11 million, compared to CHF 194 million in 2018, due to an increase in receivables and inventories, as well as a decrease in payable and contract liabilities.

2019 outlook adjusted

Global economic slowdown is expected to prevail in the second half of 2019, with looming threats from geopolitical instabilities and concerns that trade disputes could intensify. Oerlikon’s key regional and end markets are exposed to these risks to a certain extent. Industrial activity and weakness in markets such as automotive, tooling and general industries are expected to further deteriorate, with no respite currently in sight. As a result, Oerlikon is adjusting its guidance. Despite the aforementioned environment, Group orders, sales and the EBITDA margin are projected to be sustained at around the same level as in 2018. Specifically, order intake is anticipated to reach up to CHF 2.7 billion, sales are to exceed CHF 2.6 billion and the EBITDA margin is to be around 15.5 per cent.

Surface Solutions Segment

The adverse trends in end markets have impacted top-line development in the Surface Solutions Segment. Order intake went down by 5.3 per cent and sales by 3.8 per cent. A decrease in sales was registered across almost all end markets. Tooling saw weak demand in China and the USA, while general industries, encompassing sectors like semiconductor and electronics, recorded lower sales in Europe and the USA. Although sales in the aerospace sector waned in the USA, a healthy demand was noted in Europe and Asia. While the aerospace sector faces industry-specific challenges, the market remains one with opportunities. In the oil and gas sector, a slight pickup in demand was observed.

The automotive sector, most notably in China, remained downbeat. Structural growth initiatives at Oerlikon have been compensating for the market downturn. However, the dip in global car production and volumes has started to impact the segment – a case in point is the 5.7 per cent decrease in Oerlikon’s second-quarter automotive sales compared to the 6.1 per cent decline in global car production. To mitigate the impact of further market deterioration, Oerlikon has actively taken stringent cost-saving measures.

Moreover, Oerlikon’s resilient business model, innovative spirit and technology leadership in long-term attractive markets place it in a strong position to take advantage of opportunities when markets recover. Additive manufacturing will play a key role in next generation of industrial applications and Oerlikon is committed to further advance the industrialization of additive manufacturing. However, the adoption of additive manufacturing in industries has progressed at a slower-than-anticipated pace and is further impaired by the deterioration of industrial activity and declining capital investments in production capacity. Consequently, top line in the additive manufacturing business has developed less dynamically than expected and the built-up capacity is currently underutilized – both factors negatively influenced the segment’s EBITDA margin by around 300 basis points.

The aforementioned additive manufacturing impacts, the weakening of margin quality from the higher proportion of lower-margin businesses and the higher operating expenses incurred for investments in future growth, such as competence centres and digitalisation initiatives, have diluted the EBITDA margin, which came in lower year-over-year at 16.8 per cent. EBIT for Q2 2019 stood at CHF 21 million (Q2 2018: CHF 45 million) and the EBIT margin was 5.6 per cent (Q2 2018: 11.4 per cent).

In the second quarter, Oerlikon Balzers strengthened its footprint with a new customer center in St. Louis, USA, to provide services for cutting and forming tools to customers in the aerospace, automotive and general industries. It also opened two customer centers in Sweden to shorten delivery times and reduce carbon footprints. In the USA, Oerlikon inaugurated its state-of-the-art R&D and production facility in Huntersville for its additive manufacturing business.

Oerlikon is partnering with Safran, the French National Centre for Scientific Research (CNRS) and the University of Limoges, to create a joint research laboratory, PROTHEIS, and a technology platform, SAFIR, in Limoges. The focus is to develop enhanced surface treatment solutions for aerospace applications – particularly, to make lighter and longer-lasting REACH-compliant products that are capable of reducing noise and nitrogen oxide emissions. Oerlikon is also collaborating with MT Aerospace to bring efficient and cost-saving end-to-end additive manufacturing solutions for customers in the aerospace and defense industries.

Manmade fibres segment

The manmade fibres segment succeeded in sustaining its high level of performance – increasing order intake by 5.7 per cent and sales by 18.5 per cent in the second quarter. Sales in the second quarter represented the highest level of sales achieved by the segment since 2013. Sales growth was recorded primarily in textile applications such as filament equipment and texturing, and was substantiated by a healthy demand for systems used in industrial yarn spinning (special filament) and nonwovens (plant engineering). A decrease in demand for carpet yarn technologies was noted, which was a development to be expected following a very strong demand for these technologies in 2018.

Sales increased significantly in Europe (>140 per cent), albeit from a low base, while China saw a healthy 26 per cent growth. A decline in sales was registered in North America (-15 per cent) and in India (-85 per cent) compared to the second quarter of 2018.

The segment significantly improved operating profitability with an EBITDA margin of 17.8 per cent for Q2 2019. This is attributed to disciplined cost management, a larger number of higher-margin projects in the mix and one-time customer effects. As a number of lower-margin projects from the down cycle and recovery periods are expected to be delivered and recognized in the second half of the year, the high EBITDA margin from the second quarter is not expected to be sustained in the upcoming quarters. EBIT for Q2 2019 stood at CHF 51 million (Q2 2018: CHF 26 million) and the EBIT margin was 15.7 per cent (Q2 2018: 9.5 per cent).

At the ITMA Barcelona show, the segment presented four world premieres in new and innovative industrial designs, partly combined with digital solutions. The eAFK Evo texturing system offers significantly higher production speeds, greater productivity and consistently high product quality, along with lower energy consumption and simpler operation. The segment also presented the latest member of its WINGS family FDY PA6 – these winders are able to smoothly handle fully drawn yarn (FDY) in the challenging polyamide 6 process. Also making its debut was Oerlikon Neumag’s BCF S8 Tricolor – a system that allows the production of more than 2,00,000 different color shades, superior spinning speed, 99 per cent system efficiency and potential energy savings of up to 5 per cent per kilogram of yarn. Last but not least, Oerlikon Barmag, in cooperation with its joint venture company BBEngineering, presented a clean technology solution called VacuFul – a vacuum filter that removes volatile contamination in spinning post-production.

Oerlikon engineers materials, equipment and surfaces and provides expert services to enable customers to have high-performance products and systems with extended lifespans. Drawing on its key technological competencies and strong financial foundation, the Group is sustaining mid-term growth by executing three strategic drivers: addressing attractive growth markets, securing structural growth and expanding through targeted mergers and acquisitions. A leading global technology and engineering Group, Oerlikon operates its business in two segments – Surface Solutions and Manmade Fibers – and has a global footprint of more than 10 500 employees at 175 locations in 37 countries. In 2018, Oerlikon generated CHF 2.6 billion in sales and invested around CHF 120 million in R&D.

CATEGORIES
TAGS
Share This

COMMENTS

Wordpress (59)
  • comment-avatar

    walgreen generic allergy pills strongest otc allergy med walgreen generic allergy pills

  • comment-avatar

    order prednisone 10mg generic generic prednisone 10mg

  • comment-avatar

    best medications for heartburn clozaril where to buy

  • comment-avatar

    most effective acne pills ranked order deltasone acne oral medication for teenagers

  • comment-avatar

    best painkiller for stomach pain order metformin sale

  • comment-avatar

    cheap accutane 40mg order accutane online accutane 40mg cheap

  • comment-avatar
  • comment-avatar

    amoxicillin online amoxil price cheap amoxil without prescription

  • comment-avatar

    buy generic omnacortil 10mg prednisolone 10mg cost order prednisolone 40mg online

  • comment-avatar

    cheap amoxicillin 500mg oral amoxil 1000mg order amoxil 1000mg generic

  • comment-avatar

    order doxycycline 200mg order vibra-tabs online

  • comment-avatar

    buy clavulanate generic buy amoxiclav for sale

  • comment-avatar

    buy synthroid 100mcg without prescription order synthroid 75mcg pill purchase levothyroxine online cheap

  • comment-avatar

    buy levitra 20mg for sale buy cheap levitra

  • comment-avatar

    clomiphene cost oral clomid 100mg clomid 100mg generic

  • comment-avatar

    purchase tizanidine sale tizanidine online order tizanidine over the counter

  • comment-avatar

    order rybelsus pills semaglutide 14 mg us purchase semaglutide pills

  • comment-avatar

    prednisone online order deltasone sale prednisone cheap

  • comment-avatar

    brand rybelsus 14 mg buy rybelsus 14mg online order rybelsus 14mg without prescription

  • comment-avatar

    accutane 20mg brand buy isotretinoin 10mg sale cost accutane

  • comment-avatar

    amoxil sale order amoxicillin for sale order amoxicillin 1000mg generic

  • comment-avatar

    zithromax 250mg cost buy zithromax generic zithromax us

  • comment-avatar

    order synthroid 100mcg for sale buy synthroid no prescription purchase synthroid without prescription

  • comment-avatar

    buy clomiphene 50mg generic order clomid 50mg sale purchase clomiphene online cheap

  • comment-avatar

    purchase sildenafil for sale viagra 50mg uk viagra order online

  • comment-avatar

    doxycycline 100mg for sale order monodox online cheap purchase monodox without prescription

  • comment-avatar

    buy hydroxychloroquine 400mg without prescription buy hydroxychloroquine 200mg hydroxychloroquine order online

  • comment-avatar

    where can i buy cenforce cenforce where to buy buy cenforce pill

  • comment-avatar

    orlistat uk orlistat order online diltiazem order online

  • comment-avatar

    acyclovir 400mg without prescription order zyloprim 100mg pill zyloprim 300mg oral

  • comment-avatar

    brand domperidone buy tetracycline 500mg online cheap purchase sumycin for sale

  • comment-avatar

    prilosec for sale online omeprazole usa buy cheap prilosec

  • comment-avatar

    lopressor order metoprolol tablet buy metoprolol 50mg sale

  • comment-avatar

    … [Trackback]

    […] Find More Information here on that Topic: indiantextilejournal.com/oerlikon-sales-increase-in-first-half-of-2019/ […]

  • comment-avatar

    generic ketorolac colchicine medication colchicine 0.5mg without prescription

  • comment-avatar

    tenormin cost order tenormin pill atenolol 50mg usa

  • comment-avatar

    buy medrol 4mg online depo-medrol generic fda methylprednisolone

  • comment-avatar

    buy propranolol sale purchase clopidogrel without prescription buy generic clopidogrel online

  • comment-avatar

    buy a dissertation affordable thesis writing do my term paper

  • comment-avatar

    methotrexate 5mg sale buy methotrexate for sale buy coumadin pills

  • comment-avatar

    metoclopramide brand buy maxolon without prescription buy losartan pills for sale

  • comment-avatar

    buy mobic sale brand celebrex 200mg celecoxib pills

  • comment-avatar

    order tamsulosin 0.4mg sale tamsulosin for sale order celebrex 100mg pills

  • comment-avatar

    zofran order online order spironolactone without prescription purchase aldactone pill

  • comment-avatar

    simvastatin ca buy generic simvastatin 20mg valacyclovir cost

  • comment-avatar

    acillin where to buy purchase penicillin online amoxil for sale

  • comment-avatar

    order baycip online cheap – order septra pill buy augmentin 625mg generic

  • comment-avatar

    purchase ciprofloxacin for sale – oral augmentin 375mg augmentin 1000mg price

  • comment-avatar

    buy ciprofloxacin no prescription – order trimox sale
    order erythromycin 250mg online

  • comment-avatar

    ivermectin 3 mg over the counter – buy suprax paypal order generic sumycin

  • comment-avatar

    cheap valtrex 1000mg – buy zovirax 400mg generic buy acyclovir pills

  • comment-avatar

    purchase lasix generic – purchase prograf captopril 25 mg tablet

  • comment-avatar

    cheap glucophage – brand duricef 500mg buy lincocin 500mg online cheap

  • comment-avatar

    cheap quetiapine 50mg – where can i buy eskalith buy eskalith

  • comment-avatar

    buy anafranil without prescription – sinequan 25mg pill sinequan online

  • comment-avatar

    order generic amoxiclav – order bactrim 480mg without prescription purchase baycip online cheap

  • comment-avatar

    ivermectin and covid – levofloxacin 500mg pills buy cefaclor tablets

  • comment-avatar

    … [Trackback]

    […] Read More Info here to that Topic: indiantextilejournal.com/oerlikon-sales-increase-in-first-half-of-2019/ […]

  • comment-avatar

    Appreciation to my father who informed me regarding this weblog, this web site is truly awesome.

  • Disqus ( )